Nyxoah S.A. (NYXH)
NYXH Stock Price Chart
Explore Nyxoah S.A. interactive price chart. Choose custom timeframes to analyze NYXH price movements and trends.
NYXH Company Profile
Discover essential business fundamentals and corporate details for Nyxoah S.A. (NYXH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Specialties
IPO Date
28 Apr 2021
Employees
163.00
Website
https://www.nyxoah.comCEO
Olivier Taelman
Description
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
NYXH Financial Timeline
Browse a chronological timeline of Nyxoah S.A. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is -$0.47, while revenue estimate is $8.64m.
Earnings released on 12 May 2026
EPS came in at -$0.43 surpassing the estimated -$0.54 by +20.37%, while revenue for the quarter reached $7.36m , beating expectations by +4.44%.
Earnings released on 19 Mar 2026
EPS came in at -$0.68 falling short of the estimated -$0.65 by -4.62%, while revenue for the quarter reached $6.63m , beating expectations by +19.31%.
Earnings released on 13 Nov 2025
EPS came in at -$0.74 falling short of the estimated -$0.61 by -21.31%, while revenue for the quarter reached $2.31m , missing expectations by -59.37%.
Earnings released on 18 Aug 2025
EPS came in at -$0.63 falling short of the estimated -$0.62 by -1.61%, while revenue for the quarter reached $1.58m , missing expectations by -40.70%.
Earnings released on 14 May 2025
EPS came in at -$0.63 falling short of the estimated -$0.49 by -28.57%, while revenue for the quarter reached $1.17m , missing expectations by -20.50%.
Earnings released on 13 Mar 2025
EPS came in at -$0.49 falling short of the estimated -$0.46 by -6.52%, while revenue for the quarter reached $1.31m , missing expectations by -44.64%.
Earnings released on 6 Nov 2024
EPS came in at -$0.55 falling short of the estimated -$0.46 by -19.57%, while revenue for the quarter reached $1.39m , missing expectations by -31.08%.
Earnings released on 6 Aug 2024
EPS came in at -$0.46 falling short of the estimated -$0.45 by -2.22%, while revenue for the quarter reached $829.01k , missing expectations by -57.70%.
Earnings released on 14 May 2024
EPS came in at -$0.45 matching the estimated -$0.45, while revenue for the quarter reached $1.31m , beating expectations by +1.68%.
Earnings released on 5 Mar 2024
EPS came in at -$0.41 matching the estimated -$0.41, while revenue for the quarter reached $2.01m , beating expectations by +4.73%.
Earnings released on 8 Nov 2023
EPS came in at -$0.29 surpassing the estimated -$0.48 by +39.58%, while revenue for the quarter reached $1.03m , missing expectations by -29.64%.
Earnings released on 8 Aug 2023
EPS came in at -$0.49 falling short of the estimated -$0.45 by -8.89%, while revenue for the quarter reached $1.21m , beating expectations by +2.36%.
Earnings released on 16 May 2023
EPS came in at -$0.49 falling short of the estimated -$0.37 by -32.43%, while revenue for the quarter reached $479.46k , missing expectations by -63.50%.
Earnings released on 22 Mar 2023
EPS came in at -$0.52 falling short of the estimated -$0.28 by -85.71%, while revenue for the quarter reached $1.41m , missing expectations by -55.65%.
Earnings released on 8 Nov 2022
EPS came in at -$0.24 surpassing the estimated -$0.30 by +20.00%, while revenue for the quarter reached $177.74k , missing expectations by -87.02%.
Earnings released on 8 Aug 2022
EPS came in at -$0.21 surpassing the estimated -$0.32 by +34.38%, while revenue for the quarter reached $978.03k , missing expectations by -11.57%.
Earnings released on 9 May 2022
EPS came in at -$0.29 falling short of the estimated -$0.26 by -11.54%, while revenue for the quarter reached $730.04k , beating expectations by +40.96%.
Earnings released on 25 Mar 2022
EPS came in at -$0.28 falling short of the estimated -$0.27 by -2.06%, while revenue for the quarter reached $334.44k , missing expectations by -46.06%.
Earnings released on 25 Nov 2021
EPS came in at -$0.40 falling short of the estimated -$0.23 by -75.48%, while revenue for the quarter reached $235.62k .
Earnings released on 31 Aug 2021
EPS came in at -$0.38 falling short of the estimated -$0.19 by -100.00%, while revenue for the quarter reached $201.70k , beating expectations by +7.86%.
NYXH Stock Performance
Access detailed NYXH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
